Esperion Therapeutics: Q1 Earnings Snapshot

ANN ARBOR, Mich. (AP) _ Esperion Therapeutics Inc. (ESPR) on Tuesday reported a loss of $90.9 million in its first quarter.

The Ann Arbor, Michigan-based company said it had a loss of $3.50 per share.

The results missed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of $2.08 per share.

The biopharmaceutical company posted revenue of $8 million in the period, which also fell short of Street forecasts. Four analysts surveyed by Zacks expected $20.4 million.

Esperion Therapeutics shares have decreased almost 2% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $25.59, a decrease of 35% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ESPR at https://www.zacks.com/ap/ESPR